European Pharmaceutical Review podcast
Latest Episodes
EPR Podcast 24 – Developing modifier gene therapy – Ocugen
Featuring Dr Neena Haider, Faculty member at Harvard Medical School and Dr Arun Upadhyay, CSO of Ocugen
EPR Podcast 23 – Inspiring inclusion in pharma – Kylie Bromley, Biogen
Featuring Dr Kylie Bromley, Vice President and Managing Director of Biogen UK and Ireland
EPR Podcast 22 – Pharmaceutical packaging – Manu Kittanakere, Gilead
Featuring Manu Kittanakere, Associate Director of Packaging Engineering at Gilead
EPR Podcast Episode 21 – Biosimilars – Salim Benkhalifa, Celltrion Healthcare France
Featuring Dr Salim Benkhalifa, Medical Affairs Lead, Celltrion Healthcare France
EPR Podcast 20 – RNAi Therapeutics – Paul Nioi, Alnylam Pharmaceuticals
Featuring Paul Nioi, Vice President of Discovery and Translational Research at Alnylam Pharmaceuticals
EPR Podcast 19 – Collaboration in microbiology – Allison Scott, Lynn Johnson and Miriam Guest, M³ Collaboration
Featuring Allison Scott, Lynn Johnson and Miriam Guest, M Collaboration
EPR Podcast Episode 18 – Embracing continuous manufacturing – Trish Hurter, Lyndra Therapeutics
Featuring Patricia Hurter, CEO of Lyndra Therapeutics
EPR Podcast Episode 17 – Antimicrobial Resistance – Boumediene Soufi, Sandoz
Featuring Dr Boumediene Soufi, Head of Antimicrobial Resistance at Sandoz
EPR Podcast Episode 16 – Evolving QC for Cell & Gene Therapy – Félix Montero Julian and Thomas Jones, bioMérieux
Whats new in the cell and gene therapy landscape? What is the role of quality control in efforts to scale up manufacturing of CGT products and alleviate talent constraints? Find out more in this podc
EPR Podcast Episode 15 – Modernising microbiology – Sophie Bailes and Miriam Guest, AstraZeneca
Featuring Sophie Bailes and Miriam Guest, AstraZeneca